Form 4: Structure Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Crespo Blas Coll, CHIEF MEDICAL OFFICER of Structure Therapeutics Inc., sold 4,008 shares of common stock on September 18, 2026 for $36.15 per share.
Summary
- Tax/exercise-price withholding: disposed of 10,626 Ordinary Shares at $11.67 ($124,005) on September 18, 2026; holds 270,252 after (Direct).
- Conversion of derivative: disposed of 12,024 Ordinary Shares on September 21, 2026; holds 258,228 after (Direct).
- Conversion of derivative: acquired 4,008 American Depositary Shares on September 21, 2026; holds 5,165 after (Direct).
- Open-market sale: disposed of 4,008 American Depositary Shares at $36.15 ($144,873) on September 21, 2026; holds 1,157 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $144,873 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Crespo Blas Coll — Officer (CHIEF MEDICAL OFFICER)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-18 | Tax/exercise-price withholding | Ordinary Shares | 10,626 | $12 | $124.0K | 270,252 |
| 2026-09-21 | Conversion of derivative | Ordinary Shares | 12,024 | — | — | 258,228 |
| 2026-09-21 | Conversion of derivative | American Depositary Shares | 4,008 | — | — | 5,165 |
| 2026-09-21 | Open-market sale | American Depositary Shares | 4,008 | $36 | $144.9K | 1,157 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-18 | Tax/exercise-price withholding (10,626 shares) |
| 2026-09-21 | Conversion of derivative (12,024 shares) |
| 2026-09-21 | Conversion of derivative (4,008 shares) |
| 2026-09-21 | Open-market sale (4,008 shares) |
Keywords
insider transaction, Form 4, GPCR, Structure Therapeutics Inc., bearish, Crespo Blas Coll
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.